会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity
    • 用于诊断和治疗体重紊乱(包括肥胖)的组合物和方法
    • US06727348B2
    • 2004-04-27
    • US09893238
    • 2001-06-27
    • Karen MooreDeborah Lynn Nagle
    • Karen MooreDeborah Lynn Nagle
    • C07K100
    • C07K14/47C07K2319/00C07K2319/02
    • The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany gene, and hosts which have been transformed by these expression systems, including transgenic animals. The invention also encompasses novel mahogany gene products, including mahogany proteins, polypeptides and peptides containing amino acid sequences mahogany proteins, fusion proteins of mahogany proteins polypeptides and peptides, and antibodies directed against such mahogany gene products. The present invention also relates to methods and compositions for the diagnosis and treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia, and for the identification of subjects susceptible to such disorders. Further, the invention relates to methods of using the mahogany gene and gene products of the invention for the identification of compounds which modulate the expression of the mahogany gene and/or the activity of the mahogany gene product. Such compounds can be useful as therapeutic agents in the treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia.
    • 本发明涉及哺乳动物红木基因,包括人类桃花心木基因,它们是参与控制哺乳动物体重的新基因。 本发明包括桃花心木基因的核苷酸序列,桃花心木基因的宿主细胞表达系统以及由这些表达系统转化的宿主,包括转基因动物。 本发明还包括新颖的桃花心木基因产物,包括桃花心木蛋白,多肽和含有氨基酸序列桃花心木蛋白的肽,桃花心木蛋白多肽和肽的融合蛋白,以及针对这种桃花心木基因产物的抗体。 本发明还涉及用于诊断和治疗哺乳动物体重障碍(包括肥胖症,恶病质和厌食症)的方法和组合物,以及用于鉴定易受此类疾病影响的受试者。 此外,本发明涉及使用本发明的桃花心木基因和基因产物来鉴定调节桃花心木基因表达的化合物和/或桃花心木基因产物的活性的方法。 这些化合物可用作治疗哺乳动物体重障碍(包括肥胖症,恶病质和厌食)的治疗剂。
    • 3. 发明授权
    • Methods and compositions for dual extraction of protein and nucleic acid
    • 双重提取蛋白质和核酸的方法和组合物
    • US08927214B2
    • 2015-01-06
    • US13450039
    • 2012-04-18
    • Michele Susan YarnallWenling WangKaren MooreMary Fielder
    • Michele Susan YarnallWenling WangKaren MooreMary Fielder
    • C12Q1/68C12P19/34
    • C07K1/145C12N15/1003C12Q1/6895
    • The present invention provides a method of isolating nucleic acid and protein from the same biological sample, comprising, in the following order: a) disrupting the biological sample; b) contacting the disrupted biological sample of (a) with a protein lysis buffer that lacks any component that denatures or reduces protein to produce a first lysate; c) centrifuging the first lysate of (b) to produce a first supernatant containing protein and a pellet containing nucleic acid; d) removing the first supernatant of (c), thereby isolating protein from the biological sample; e) contacting the pellet of (d) with nucleic acid lysis buffer to produce a second lysate; f) centrifuging the second lysate of (e) to produce a second supernatant containing nucleic acid; and g) removing the second supernatant of (f), thereby isolating nucleic acid from the same biological sample.
    • 本发明提供了从同一生物样品中分离核酸和蛋白质的方法,其包括以下顺序:a)破坏生物样品; b)使破坏的(a)生物样品与蛋白质裂解缓冲液接触,所述蛋白质裂解缓冲液缺乏任何成分变性或降低蛋白质以产生第一裂解物的成分; c)离心(b)的第一裂解物以产生含有蛋白质的第一上清液和含有核酸的沉淀物; d)除去(c)的第一上清液,从而从生物样品中分离蛋白质; e)使(d)的沉淀与核酸裂解缓冲液接触以产生第二裂解物; f)离心(e)的第二裂解物以产生含有核酸的第二上清液; 和g)除去(f)的第二上清液,从而分离来自相同生物样品的核酸。
    • 4. 发明申请
    • Pipeline including network and topology for identifying, locating and quantifying physical phenomena
    • 管道包括用于识别,定位和量化物理现象的网络和拓扑
    • US20050092098A1
    • 2005-05-05
    • US10991767
    • 2004-11-17
    • John RichardsonKaren MooreRobert Carrington
    • John RichardsonKaren MooreRobert Carrington
    • G01M3/18G01N27/20G01N3/32
    • G01N27/205G01M3/18
    • A method and system for detecting, locating and quantifying a physical phenomena such as strain or a deformation in a structure. A plurality of laterally adjacent conductors may each include a plurality of segments. Each segment is constructed to exhibit a unit value representative of a defined energy transmission characteristic. A plurality of identity groups are defined with each identity group comprising a plurality of segments including at least one segment from each of the plurality of conductors. The segments contained within an identity group are configured and arranged such that each of their associated unit values may be represented by a concatenated digit string which is a unique number relative to the other identity groups. Additionally, the unit values of the segments within an identity group maintain unique ratios with respect to the other unit values in the identity group.
    • 用于检测,定位和量化结构中的应变或变形的物理现象的方法和系统。 多个横向相邻的导体可以各自包括多个段。 每个段被构造为表现出代表定义的能量传输特性的单位值。 多个身份组被定义为每个身份组包括多个段,其包括来自多个导体中的每一个的至少一个段。 包含在身份组内的段被配置和排列成使得它们的相关单位值中的每一个可以由连接的数字串表示,该数字串是相对于其他身份组的唯一编号。 另外,身份组中段的单位值相对于身份组中的其他单位值保持唯一的比率。
    • 6. 发明申请
    • Structures including network and topology for identifying, locating and quantifying physical phenomena
    • 包括用于识别,定位和量化物理现象的网络和拓扑结构
    • US20050097965A1
    • 2005-05-12
    • US10992440
    • 2004-11-17
    • John RichardsonKaren MooreRobert Carrington
    • John RichardsonKaren MooreRobert Carrington
    • G01M3/18G01N27/20G01N3/32
    • G01N27/205G01M3/18
    • A method and system for detecting, locating and quantifying a physical phenomena such as strain or a deformation in a structure. A plurality of laterally adjacent conductors may each include a plurality of segments. Each segment is constructed to exhibit a unit value representative of a defined energy transmission characteristic. A plurality of identity groups are defined with each identity group comprising a plurality of segments including at least one segment from each of the plurality of conductors. The segments contained within an identity group are configured and arranged such that each of their associated unit values may be represented by a concatenated digit string which is a unique number relative to the other identity groups. Additionally, the unit values of the segments within an identity group maintain unique ratios with respect to the other unit values in the identity group.
    • 用于检测,定位和量化结构中的应变或变形的物理现象的方法和系统。 多个横向相邻的导体可以各自包括多个段。 每个段被构造为表现出代表定义的能量传输特性的单位值。 多个身份组被定义为每个身份组包括多个段,其包括来自多个导体中的每一个的至少一个段。 包含在身份组内的段被配置和排列成使得它们的相关单位值中的每一个可以由连接的数字串表示,该数字串是相对于其他身份组的唯一编号。 另外,身份组中段的单位值相对于身份组中的其他单位值保持唯一的比率。
    • 7. 发明授权
    • Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity
    • 用于诊断和治疗体重障碍的方法和组合物,包括肥胖症
    • US06274339B1
    • 2001-08-14
    • US09245041
    • 1999-02-05
    • Karen MooreDeborah Lynn Nagle
    • Karen MooreDeborah Lynn Nagle
    • A01K67027
    • C07K14/47C07K2319/00C07K2319/02
    • The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany gene, and hosts which have been transformed by these expression systems, including transgenic animals. The invention also encompasses novel mahogany gene products, including mahogany proteins, polypeptides and peptides containing amino acid sequences mahogany proteins, fusion proteins of mahogany proteins polypeptides and peptides, and antibodies directed against such mahogany gene products. The present invention also relates to methods and compositions for the diagnosis and treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia, and for the identification of subjects susceptible to such disorders. Further, the invention relates to methods of using the mahogany gene and gene products of the invention for the identification of compounds which modulate the expression of the mahogany gene and/or the activity of the mahogany gene product. Such compounds can be useful as therapeutic agents in the treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia.
    • 本发明涉及哺乳动物红木基因,包括人类桃花心木基因,它们是参与控制哺乳动物体重的新基因。 本发明包括桃花心木基因的核苷酸序列,桃花心木基因的宿主细胞表达系统以及由这些表达系统转化的宿主,包括转基因动物。 本发明还包括新颖的桃花心木基因产物,包括桃花心木蛋白,多肽和含有氨基酸序列桃花心木蛋白的肽,桃花心木蛋白多肽和肽的融合蛋白,以及针对这种桃花心木基因产物的抗体。 本发明还涉及用于诊断和治疗哺乳动物体重障碍(包括肥胖症,恶病质和厌食症)的方法和组合物,以及用于鉴定易受此类疾病影响的受试者。 此外,本发明涉及使用本发明的桃花心木基因和基因产物来鉴定调节桃花心木基因表达的化合物和/或桃花心木基因产物的活性的方法。 这些化合物可用作治疗哺乳动物体重障碍(包括肥胖症,恶病质和厌食)的治疗剂。
    • 10. 发明授权
    • Methods and composition for the diagnosis and treatment of body weight disorders, including obesity
    • 用于诊断和治疗体重紊乱(包括肥胖)的方法和组成
    • US06713277B1
    • 2004-03-30
    • US09358055
    • 1999-07-21
    • Karen MooreDeborah Lynn Nagle
    • Karen MooreDeborah Lynn Nagle
    • C12P2106
    • C07K14/47C07K2319/00C07K2319/02
    • The present invention relates to mammalian mahogany genes, including the human mahogany gene, which are novel genes involved in the control of mammalian body weight. The invention encompasses nucleotide sequences of the mahogany gene, host cell expression systems of the mahogany gene, and hosts which have been transformed by these expression systems, including transgenic animals. The invention also encompasses novel mahogany gene products, including mahogany proteins, polypeptides and peptides containing amino acid sequences mahogany proteins, fusion proteins of mahogany proteins polypeptides and peptides, and antibodies directed against such mahogany gene products. The present invention also relates to methods and compositions for the diagnosis and treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia, and for the identification of subjects susceptible to such disorders. Further, the invention relates to methods of using the mahogany gene and gene products of the invention for the identification of compounds which modulate the expression of the mahogany gene and/or the activity of the mahogany gene product. Such compounds can be useful as therapeutic agents in the treatment of mammalian body weight disorders, including obesity, cachexia, and anorexia.
    • 本发明涉及哺乳动物红木基因,包括人类桃花心木基因,它们是参与控制哺乳动物体重的新基因。 本发明包括桃花心木基因的核苷酸序列,桃花心木基因的宿主细胞表达系统以及由这些表达系统转化的宿主,包括转基因动物。 本发明还包括新颖的桃花心木基因产物,包括桃花心木蛋白,多肽和含有氨基酸序列桃花心木蛋白的肽,桃花心木蛋白多肽和肽的融合蛋白,以及针对这种桃花心木基因产物的抗体。 本发明还涉及用于诊断和治疗哺乳动物体重障碍(包括肥胖症,恶病质和厌食症)的方法和组合物,以及用于鉴定易受此类疾病影响的受试者。 此外,本发明涉及使用本发明的桃花心木基因和基因产物来鉴定调节桃花心木基因表达的化合物和/或桃花心木基因产物的活性的方法。 这些化合物可用作治疗哺乳动物体重障碍(包括肥胖症,恶病质和厌食)的治疗剂。